Darren Mooney
@Pfm Health Sciences, Lp
Latest period2024 - Q3ReportedManaged Assets$1.765BTotal holdings74
Assets growth rate-12.66%Assets growth rate (2-Q avg)-8.83%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Pfm Health Sciences, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 74 positions.
Assets under management
The assets under management (AUM) of Pfm Health Sciences, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.765B in assets, with a quarterly growth rate of -12.66% and a 2-quarter average growth rate of -8.83%. The portfolio is managed by Darren Mooney, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
INSPInspire Med Sys Inc
| 1.18% | $20.751M 98,322 shares@ $211.05 avg price | New Position |
ASNDAscendis Pharma A S
| 0.77% | $13.552M 90,766 shares@ $149.31 avg price | New Position |
CONConcentra Group Holdings Par
| 0.39% | $6.708M 300,000 shares@ $22.36 avg price | New Position |
TGTXTg Therapeutics Inc
| 0.31% | $5.459M 233,410 shares@ $23.4 avg price | New Position |
VEEVVeeva Sys Inc
| 0.23% | $4.042M 19,259 shares@ $209.87 avg price | New Position |
LBPHLongboard Pharmaceuticals In
| 0.22% | $3.79M 113,711 shares@ $33.34 avg price | New Position |
OCULOcular Therapeutix Inc
| 0.2% | $3.505M 402,843 shares@ $8.7 avg price | New Position |
LUNGPulmonx Corp
| 0.18% | $3.058M 368,929 shares@ $8.29 avg price | New Position |
CAPRCapricor Therapeutics Inc
| 0.14% | $2.324M 152,779 shares@ $15.22 avg price | New Position |
ARKGArk Etf Tr
| 0.13% | $2.226M 86,934 shares@ $25.6 avg price | New Position |